The 2026 Patient Safety and Quality Improvement Act introduces significant changes for MedTech reporting. This article delves into the core aspects of the act, its implications for medical device manufacturers, and strategies for ensuring compliance and enhancing patient safety.

This comprehensive guide provides medical device manufacturers with essential insights and actionable strategies to achieve UDI compliance by 2026, covering regulatory updates, data management, and implementation best practices.

This article delves into the projected 2026 Medicare Part B policy changes concerning Durable Medical Equipment (DME). We analyze potential cost impacts for beneficiaries and providers, offering insights and preparation strategies.

The landscape for high-risk medical device clinical trials is evolving significantly with critical updates slated for 2026. This article provides an in-depth look at the upcoming regulatory changes, offering essential insights for manufacturers to ensure compliance and successful market access.

The healthcare landscape is rapidly evolving with AI. MedTech companies must understand the 2026 CMS reimbursement codes for AI-powered diagnostics to ensure market access and financial viability. This article provides a comprehensive guide.

The 2026 National Health IT Policy Shifts are poised to redefine EHR integration for MedTech. This article delves into key changes, challenges, and opportunities, offering strategic guidance for companies to navigate the evolving landscape.

The FDA's 2026 Premarket Approval (PMA) changes are on the horizon, bringing significant shifts for medical device manufacturers. This article outlines a crucial 5-point action plan to help companies navigate these updates, ensuring compliance and successful market entry.

Understand the evolving 2026 regulatory landscape for breakthrough medical devices. This guide delves into strategies for accelerating market access, highlighting key changes, challenges, and opportunities for developers and innovators in the healthcare sector.

This article provides a comprehensive 3-step compliance checklist for medical device manufacturers to navigate the complexities of 2026 FDA device recalls, ensuring preparedness and minimizing regulatory risks.

The 2026 Cures Act 2.0 is set to reshape digital health device approvals. This article delves into the anticipated changes, offering insights for developers, manufacturers, and healthcare providers to navigate the evolving regulatory landscape.